Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L R Prosnitz

Showing results (11-20 of 123) with videos related to

Pageof 13
Sort By:
JAMA|February 22, 1995
Estrogen replacement therapy in breast cancer survivorsL R Prosnitz
International Journal of Radiation Oncology, Biology, Physics|September 1, 1990
Hodgkin's disease: the right doseL R Prosnitz
International Journal of Radiation Oncology, Biology, Physics|October 1, 1987
Therapy of IIIA Hodgkin's diseaseL R Prosnitz
International Journal of Radiation Oncology, Biology, Physics|July 1, 1988
Radiation complications for Hodgkin's disease and seminoma: assessing the risk:benefit ratioL R Prosnitz
Radiology|August 1, 1975
Mantle field dosimetry comparing 4 MV with cobalt 60L Gray, L R Prosnitz
Radiology|August 1, 1975
Dosimetry of Hodgkin's disease therapy using a 4 MV linear acceleratorL Gray, L R Prosnitz
Bulletin of the New York Academy of Medicine|March 1, 1982
Treatment of early breast cancer with primary radiation therapy: rationale, results, and techniquesJ B Weissberg, L R Prosnitz
Progress in Clinical Cancer|January 1, 1978
The therapy of Hodgkin's disease--1978: a combined modality approachL R Prosnitz, R L Montalvo
The Cancer Journal From Scientific American|April 13, 1999
Assessing the impact of elective regional radiotherapy on survivalL B Marks, L R Prosnitz
Cancer|February 15, 1997
"One to three" or "four or more"?: selecting patients for postmastectomy radiation therapyL B Marks, L R Prosnitz
Pageof 13

Showing results (11-20 of 123) with videos related to

Sort By:
Pageof 13
JAMA|February 22, 1995
Estrogen replacement therapy in breast cancer survivorsL R Prosnitz
International Journal of Radiation Oncology, Biology, Physics|September 1, 1990
Hodgkin's disease: the right doseL R Prosnitz
International Journal of Radiation Oncology, Biology, Physics|October 1, 1987
Therapy of IIIA Hodgkin's diseaseL R Prosnitz
International Journal of Radiation Oncology, Biology, Physics|July 1, 1988
Radiation complications for Hodgkin's disease and seminoma: assessing the risk:benefit ratioL R Prosnitz
Radiology|August 1, 1975
Mantle field dosimetry comparing 4 MV with cobalt 60L Gray, L R Prosnitz
Radiology|August 1, 1975
Dosimetry of Hodgkin's disease therapy using a 4 MV linear acceleratorL Gray, L R Prosnitz
Bulletin of the New York Academy of Medicine|March 1, 1982
Treatment of early breast cancer with primary radiation therapy: rationale, results, and techniquesJ B Weissberg, L R Prosnitz
Progress in Clinical Cancer|January 1, 1978
The therapy of Hodgkin's disease--1978: a combined modality approachL R Prosnitz, R L Montalvo
The Cancer Journal From Scientific American|April 13, 1999
Assessing the impact of elective regional radiotherapy on survivalL B Marks, L R Prosnitz
Cancer|February 15, 1997
"One to three" or "four or more"?: selecting patients for postmastectomy radiation therapyL B Marks, L R Prosnitz
Pageof 13